• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec25
AstraZeneca and JABYO Enter into a License Agreement, Jacada Shares Under Pressure
01:04
Dec22
AstraZeneca's Involvement in Jiakang KRAS Inhibitor Project Shifts Pharmaceutical Industry Competition Landscape
00:50
Dec2
JAKSION BIOSCIENCE SUBSIDIARY RECEIVES FIRST PAYMENT FROM HISON CAPITAL
04:40
Nov30
J 科思-B publishes KRAS G12C inhibitor combination therapy clinical trial results
23:49
Nov13
JACOBIOTECH-B repurchased 72,000 shares for HKD 498,300
11:29
Nov11
JAKSON BIOSCIENCE REPUCHASED 72,000 SHARES FOR HKD 482,300
10:31

Schedules & Filings

Schedules
Filings
Aug29
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 24.99 M, Net Income -32.29 M, EPS -0.0417

Mar19
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 82.83 M, Net Income 7.098 M, EPS 0.0091

Aug30
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -90.83 M, EPS -0.1169

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
08635
0.570
+28.09%
+0.125
08573
0.053
+26.19%
+0.011
03830
0.080
+25.00%
+0.016
01570
6.170
+23.40%
+1.170
02315
35.080
+22.23%
+6.380
01875
2.500
+19.05%
+0.400
00145
0.265
+17.78%
+0.040
02330
0.226
+17.71%
+0.034
00209
0.173
+16.89%
+0.025
View More